A detailed history of Wolverine Trading, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wolverine Trading, LLC holds 4,290 shares of ABT stock, worth $490,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,290
Previous 8,416 49.03%
Holding current value
$490,046
Previous $874,000 44.05%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $412,888 - $487,404
-4,126 Reduced 49.03%
4,290 $489,000
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $847,743 - $946,295
8,416 New
8,416 $874,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $2.99 Million - $3.66 Million
-33,108 Reduced 56.06%
25,951 $2.86 Million
Q3 2023

Nov 15, 2023

BUY
$95.53 - $114.62 $3.02 Million - $3.62 Million
31,589 Added 114.99%
59,059 $5.72 Million
Q2 2023

Aug 23, 2023

BUY
$100.78 - $112.29 $2.14 Million - $2.38 Million
21,224 Added 339.8%
27,470 $2.99 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $1.78 Million - $2.1 Million
-18,417 Reduced 74.67%
6,246 $619,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $1.82 Million - $2.14 Million
19,183 Added 350.05%
24,663 $2.71 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.55 Million - $1.79 Million
-16,009 Reduced 74.5%
5,480 $539,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $156,473 - $189,126
1,533 Added 7.68%
21,489 $2.34 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2.28 Million - $2.77 Million
19,956 New
19,956 $2.4 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $352,019 - $431,028
-3,047 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $355,463 - $393,245
3,047 New
3,047 $364,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $2.2 Million - $2.59 Million
-20,772 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $179,586 - $211,579
1,650 Added 8.63%
20,772 $2.49 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $461,475 - $502,875
4,395 Added 29.84%
19,122 $2.07 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $2.29 Million - $2.93 Million
-29,883 Reduced 66.99%
14,727 $1.31 Million
Q1 2020

May 11, 2020

SELL
$62.82 - $91.86 $7.31 Million - $10.7 Million
-116,399 Reduced 72.29%
44,610 $3.54 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $7.53 Million - $8.38 Million
95,874 Added 147.19%
161,009 $14 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $5.12 Million - $5.56 Million
62,621 Added 2490.89%
65,135 $5.33 Million
Q2 2019

Aug 20, 2019

SELL
$72.88 - $85.0 $122,875 - $143,310
-1,686 Reduced 40.14%
2,514 $211,000
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $278,124 - $336,252
4,200 New
4,200 $336,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $415,000 - $444,300
-7,731 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $371,551 - $414,690
7,731
7,731 $413,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.